Cargando…
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
INTRODUCTION: The aim of this study was to evaluate treatment responses, toxicity, and survival among cHL patients aged ≥50 years. METHODS: We retrospectively identified all newly diagnosed cHL patients and only included cases who were ≥50 years old at the time of diagnosis and with data available b...
Autores principales: | Çokgezer, Simay, Elverdi, Tuğrul, Salihoğlu, Ayşe, Ar, Muhlis Cem, Öngören, Şeniz, Başlar, Zafer, Eşkazan, Ahmet Emre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188373/ https://www.ncbi.nlm.nih.gov/pubmed/35698602 http://dx.doi.org/10.2147/CMAR.S363235 |
Ejemplares similares
-
Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic()
por: Küçükyurt, Selin, et al.
Publicado: (2022) -
The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience
por: Kucukyurt, Selin, et al.
Publicado: (2021) -
Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience
por: Öngören, Şeniz, et al.
Publicado: (2017) -
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience
por: Öngören, Seniz, et al.
Publicado: (2018) -
The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia
por: ESATOĞLU, Sinem Nihal, et al.
Publicado: (2021)